ExodusPoint Capital Management’s Verona Pharma VRNA Stock Holding History

ExodusPoint Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,532	Closed	-$1.34M	–	2111
2025 Q3	$1.34M	Buy	+12,532	New	+$1.31M	0.01%	859
2022 Q4	–	Sell	-239,602	Closed	-$2.45M	–	2176
2022 Q3	$2.45M	Buy	+239,602	New	+$2.02M	0.03%	703

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

ExodusPoint Capital Management's VRNA Position: Q4 2025 in Review

ExodusPoint Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 12,532 shares — an estimated $1.34M sold.

ExodusPoint Capital Management first reported a position in VRNA in Q3 2022 and held it in 2 quarters. The position peaked at $2.45M in Q3 2022. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

ExodusPoint Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 12,532 Verona Pharma shares in Q4 2025, an estimated $1.34M.
ExodusPoint Capital Management first reported a position in Verona Pharma in Q3 2022 and held it in 2 quarters.
ExodusPoint Capital Management's Verona Pharma position peaked at $2.45M in Q3 2022.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.